The ERK1/2-Elk1, JNK-cJun, and JAK-STAT Transcriptional Axes as Potential Bortezomib Resistance Mediators in Prostate Cancer
Georgios Kalampounias, Kalliopi Zafeiropoulou, Theodosia Androutsopoulou, Spyridon Alexis, Argiris S. Symeonidis, Panagiotis Katsoris
This study identifies upregulated transcription factors in Bortezomib-resistant prostate cancer cells and suggests targeting them to restore sensitivity to proteasome inhibitors.
Current Issues in Molecular Biology · May 12, 2025Peer-reviewedCancer Biology